Biotech Startups
9,603 companies tagged Biotech, with their investors and founders.
Michroma uses synthetic biology and fermentation to engineer microbial platforms that produce natural ingredients, starting with food colors. It targets the food ingredients industry, offering alternatives to petrochemical- and agriculture-derived products.
6 investors
Monte Rosa develops molecular glue degrader (MGD) therapeutics using MGD chemistry, artificial intelligence, structural biology, and proteomics to target previously undruggable or inadequately drugged disease targets. The company operates in drug discovery and pharmaceutical development.
6 investors
Mozart Therapeutics develops protein therapeutics focused on immunology and oncology treatments. The company is founded on research from Stanford University scientists and is led by experienced biopharmaceutical industry executives.
6 investors
MycoTech develops food ingredients derived from fungi using mushroom mycelial fermentation, including flavor modulation tools (ClearIQ) and a sweet protein from honey truffles for sugar reduction. It serves food and beverage companies looking to improve taste, functionality, and create clean-label products.
6 investors
Nabla is a drug development company that applies design discipline and scientific rigor to the development of new medicines. The company focuses on making drug development more systematic and iterative, serving the pharmaceutical and biotech industry.
6 investors
Nest Genomics develops genomics solutions to integrate genetic testing into routine patient care. The company is led by former Clear Genetics founders and employs genetic counselors and engineers.
6 investors
NiKang Therapeutics is a clinical-stage biotechnology company developing small molecule drugs for cancer, using structure-based drug design against targets such as HIF2Ξ±, CDK2, KRAS, and SHP2. It focuses on precision medicine for difficult-to-drug oncology targets, with three compounds advanced into first-in-human clinical testing.
6 investors
Nix develops wearable biosensors that measure health metrics like hydration in real-time for athletes, soldiers, and laborers outside traditional healthcare settings. The company's first product is a hydration biosensor designed to optimize safety and performance monitoring.
6 investors
Notable Labs operates an automated laboratory that tests combinations of existing drugs against individual patients' blood cancer cells to identify effective treatment options for patients whose cancers have become resistant to standard therapies.
6 investors
Orca Bio develops allogeneic T-cell immunotherapies for high-risk blood cancers including acute myeloid leukemia, acute lymphocytic leukemia, and myelodysplastic syndrome. The company is advancing precision cell therapy treatments for patients with blood cancers and autoimmune diseases.
6 investors
Pear Bio delivers precision medicine tests and therapeutics for patients with hard-to-treat cancers by creating personalized treatment predictions from tumor biopsies and developing novel targeted therapies.
6 investors
Pencil Biosciences develops a fully synthetic, modular, non-CRISPR gene editing platform that edits DNA without causing a break or nick. The technology targets applications in therapeutics and cell line engineering.
6 investors
Perfuse Therapeutics is a biotechnology company developing a therapy to improve blood flow to the retina, targeting ocular diseases such as glaucoma and diabetic retinopathy. The company aims to reduce blindness caused by these conditions.
6 investors
Persephone Biosciences develops a synbiotic (probiotic and prebiotic combination) supplement for infants designed to replenish key beneficial gut bacteria. The product targets parents seeking to support their babies' digestive health, immune development, and overall microbiome health.
6 investors
Persist AI provides AI-driven formulation development services for pharmaceutical compounds, combining robotic lab automation with machine learning models to accelerate drug formulation optimization and reduce time-to-market.
6 investors
Phytoform Labs develops GM-free genome editing tools and trait engineering technologies for crop improvement, with a focus on potato and tomato varieties. The company works at the intersection of biotechnology and agricultural research to advance sustainable crop breeding.
6 investors
Planet A Foods develops alternative food ingredients using food technology to reduce climate impact in the food industry. The company produces ChoViva, a no-cocoa chocolate ingredient for B2B food manufacturers seeking sustainable supply chain solutions.
6 investors
Prezent is an enterprise communication and presentation productivity platform powered by AI that helps teams increase communication effectiveness and reduce presentation production time and costs. The platform serves large organizations in the F2000.
6 investors
Quartzy provides a platform for lab management and research resource optimization, serving life scientists, lab managers, and academic institutions. The company helps manage orders, inventory, and workflows for laboratory research operations.
6 investors
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms. The company was founded by neuroscientists from Harvard to translate emerging discoveries about disease pathways into treatment breakthroughs for ALS patients.
6 investors
Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology. It draws on its team's experience across drug discovery, research, development, manufacturing, and regulatory strategy to advance rare-disease drug candidates.
6 investors
RefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that uses biological signals from radiopharmaceutical-labeled cancer cells to deliver real-time, motion-managed radiation to lung and bone tumors from primary or metastatic disease. The technology is used by cancer treatment centers, including freestanding cancer centers and hospital outpatient departments, to treat solid tumors at any stage.
6 investors
Remilk produces animal-free dairy by using microbial fermentation to recreate milk proteins identical to those in traditional dairy, without cholesterol, lactose, hormones, or antibiotics. The company targets the consumer food market with sustainable, cow-free dairy products.
6 investors
Robigo develops engineered microbial crop protection products for growers, including a biological solution targeting Sudden Death Syndrome in soybean. Its platform aims to deliver season-long yield protection against high-impact agricultural diseases while preserving beneficial organisms.
6 investors